BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30532056)

  • 1. PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia.
    Assi R; Mahfouz R; Owen R; Gunthorpe M; Chehab FF; Bazarbachi A
    Bone Marrow Transplant; 2019 Jul; 54(7):1124-1128. PubMed ID: 30532056
    [No Abstract]   [Full Text] [Related]  

  • 2. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
    Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
    [No Abstract]   [Full Text] [Related]  

  • 3. Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression.
    Ray D; Kwon SY; Tagoh H; Heidenreich O; Ptasinska A; Bonifer C
    Blood; 2013 Aug; 122(5):759-69. PubMed ID: 23616623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia.
    Coyaud E; Struski S; Dastugue N; Brousset P; Broccardo C; Bradtke J
    Leuk Res; 2010 Dec; 34(12):e323-5. PubMed ID: 20723977
    [No Abstract]   [Full Text] [Related]  

  • 5. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
    An Q; Wright SL; Konn ZJ; Matheson E; Minto L; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Hall AG; Harrison CJ; Irving JA; Strefford JC
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17050-4. PubMed ID: 18957548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.
    Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y
    Sci Rep; 2017 Nov; 7(1):16604. PubMed ID: 29192243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse.
    McClure BJ; Heatley SL; Rehn J; Breen J; Sutton R; Hughes TP; Suppiah R; Revesz T; Osborn M; White D; Yeung DT; White DL
    Br J Haematol; 2020 Oct; 191(2):301-304. PubMed ID: 32731299
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.
    Grossmann V; Schnittger S; Poetzinger F; Kohlmann A; Stiel A; Eder C; Fasan A; Kern W; Haferlach T; Haferlach C
    Leukemia; 2013 Sep; 27(9):1933-6. PubMed ID: 23535558
    [No Abstract]   [Full Text] [Related]  

  • 10. PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia.
    Shang Z; Zhao Y; Zhou K; Xu Y; Huang W
    Int J Hematol; 2013 May; 97(5):599-603. PubMed ID: 23529845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
    Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
    Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental origin of monosomy 7 in acute leukaemia.
    Lundin-Ström KB; Biloglav A; Lazarevic V; Behrendtz M; Castor A; Johansson B
    Br J Haematol; 2021 Mar; 192(5):e132-e135. PubMed ID: 33548143
    [No Abstract]   [Full Text] [Related]  

  • 13. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
    Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
    Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis.
    Isidro-Hernández M; Mayado A; Casado-García A; Martínez-Cano J; Palmi C; Fazio G; Orfao A; Ribera J; Ribera JM; Zamora L; Raboso-Gallego J; Blanco O; Alonso-López D; De Las Rivas J; Jiménez R; García Criado FJ; García Cenador MB; Ramírez-Orellana M; Cazzaniga G; Cobaleda C; Vicente-Dueñas C; Sánchez-García I
    Sci Rep; 2020 Nov; 10(1):19189. PubMed ID: 33154497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
    Bastian L; Schroeder MP; Eckert C; Schlee C; Tanchez JO; Kämpf S; Wagner DL; Schulze V; Isaakidis K; Lázaro-Navarro J; Hänzelmann S; James AR; Ekici A; Burmeister T; Schwartz S; Schrappe M; Horstmann M; Vosberg S; Krebs S; Blum H; Hecht J; Greif PA; Rieger MA; Brüggemann M; Gökbuget N; Neumann M; Baldus CD
    Leukemia; 2019 Aug; 33(8):1895-1909. PubMed ID: 30842609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
    Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
    Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
    Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
    Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic insertion of CBFB into MYH11 leading to a type D fusion in acute myeloid leukemia with normal karyotype.
    Yamamoto K; Kurata K; Kitao A; Sakai R; Matsumoto S; Matsumoto H; Saegusa J; Yakushijin K; Minami H
    Int J Lab Hematol; 2022 Feb; 44(1):e36-e39. PubMed ID: 34490987
    [No Abstract]   [Full Text] [Related]  

  • 19. A patient with B-cell acute lymphoblastic leukemia with PAX5-ETV6 rearrangement with dic(9;12)(p13;p13) identified by chromosomal microarray.
    Ha J; Kim B; Hahn S; Lee ST; Lyu CJ; Choi JR
    Ann Hematol; 2018 Aug; 97(8):1505-1507. PubMed ID: 29520434
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic growth factor receptor signaling and lineage inappropriate gene expression in AML: the polycomb connection.
    Ray D; Kwon SY; Ptasinska A; Bonifer C
    Cell Cycle; 2013 Jul; 12(14):2159-60. PubMed ID: 23803734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.